Alejandro Sousa

Dr. Alejandro Sousa


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2016 in International Journal of Hyperthermia
Verified
Journal Article
Closed access
PDF file
ASAlejandro Sousa
Alejandro Sousa
IPIdelfonso Piñeiro
Idelfonso Piñeiro
SRSilvia Rodríguez
Silvia Rodríguez
VAVicente Aparici
Vicente Aparici
VMVictor Monserrat
Victor Monserrat
CUCarlos Uribarri
Carlos Uribarri
Purpose To examine the effectiveness of hyperthermic intravesical chemotherapy (HIVEC™) with mitomycin-C (MMC) for patients with intermediate–high-risk non-muscle invasive bladder cancer (NMIBC). Materials and methods From November 2010 to April 2015, 40 patients with intermediate–high-risk NMIBC received HIVEC™ treatment with a Combat BRS system. Of these patients, 24 received neoadjuvant HIVEC™ treatment (eight weekly instillations) before a transurethral resection of the bladder (TURBT) and 16 received adjuvant HIVEC™ treatment post-TURBT (four instillations weekly + six monthly). The pathological response of each tumour was evaluated after the neoadjuvant treatment. Recurrence rates and adverse effects were evaluated in both groups. Results A total of 40 patients completed the induction therapy: 24 patients received the Neoadjuvant HIVEC™ treatment. Of these patients, 15 (62.5%) showed a complete response. Eight patients (33.3%) showed a partial response, and one patient (4.1%) showed no response at all. The 4-year cumulative incidence of recurrence was 20.8%. The adjuvant HIVEC™ treatment was given to 16 patients. The 2-year cumulative incidence of recurrence was 12.5% for this group. The incidence and severity of side effects were slightly lower in the adjuvant group than in the neoadjuvant group. However, the difference was not statistically significant (p < 0.3). Most of the side effects were low grade and had virtually no effect on the treatment plan, and 97% of patients completed all of the HIVEC™ instillations scheduled. Conclusions The recirculation of hyperthermic MMC using Combat’s HIVEC™ treatment is safe and effective and is capable of achieving good success rates in both neoadjuvant and adjuvant settings. This treatment seems to be appropriate for NMIBC intermediate–high-risk patients who cannot tolerate or have contraindications for standard BCG therapy or in cases in which there are supply issues or shortages of BCG.

30 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAna Plata bello
Ana Plata bello
Félix Guerrero-RamosFélix Guerrero-Ramos
Félix Guerrero-Ramos
CGCarlos Garcia
Carlos Garcia
AGAlejandro González-Díaz
Alejandro González-Díaz
IGIgnacio Gonzalez-Valcárcel
Ignacio Gonzalez-Valcárcel
Javier C. AnguloJavier C. Angulo
Javier C. Angulo
(1) Background: Intravesical mitomycin-C (MMC) combined with hyperthermia is increasingly used in non-muscle invasive bladder cancer (NMIBC), especially in the context of a relative BCG shortage. We aim to determine real-world data on the long-term treatment outcomes of adjunct hyperthermic intravesical chemotherapy (HIVEC) with MMC and a COMBAT® bladder recirculation system (BRS); (2) Methods: A prospective observational trial was performed on patients with NMIBC treated with HIVEC using BRS in nine academic institutions in Spain between 2012–2020 (HIVEC-E). Treatment effectiveness (recurrence, progression and overall mortality) was evaluated in patients treated with HIVEC MMC 40mg in the adjuvant setting, with baseline data and a clinical follow-up, that comprise the Full Analysis Set (FAS). Safety, according to the number and severity of adverse effects (AEs), was evaluated in the safety (SAF) population, composed by patients with at least one adjunct HIVEC MMC instillation; (3) Results: The FAS population (n = 502) received a median number of 8.78 ± 3.28 (range 1–20) HIVEC MMC instillations. The median follow-up duration was 24.5 ± 16.5 (range 1–81) months. Its distribution, based on EAU risk stratification, was 297 (59.2%) for intermediate and 205 (40.8%) for high-risk. The figures for five-year recurrence-free and progression-free survival were 50.37% (53.3% for intermediate and 47.14% for high-risk) and 89.83% (94.02% for intermediate and 84.23% for high-risk), respectively. A multivariate analysis identified recurrent tumors (HR 1.83), the duration of adjuvant HIVEC therapy <4 months (HR 1.72) and that high-risk group (HR 1.47) were at an increased risk of recurrence. Independent factors of progression were high-risk (HR 3.89), recurrent tumors (HR 3.32) and the induction of HIVEC therapy without maintenance (HR 2.37). The overall survival was determined by patient age at diagnosis (HR 3.36) and the treatment duration (HR 1.82). The SAF population (n = 592) revealed 406 (68.58%) patients without AEs and 186 (31.42%) with at least one AE: 170 (28.72%) of grade 1–2 and 16 (2.7%) of grade 3–4. The most frequent AEs were dysuria (10%), pain (7.1%), urgency (5.7%), skin rash (4.9%), spasms (3.7%) and hematuria (3.6%); (4) Conclusions: HIVEC using BRS is efficacious and well tolerated. A longer treatment duration, its use in naïve patients and the intermediate-risk disease are independent determinants of success. Furthermore, a monthly maintenance of adjunct MMC HIVEC diminishes the progression rate of NMIBC.

18 February 2021 in ACS Nano
Verified
Journal Article
Open access
FBFelix J. Berger
Felix J. Berger
ASAlejandro Sousa
Alejandro Sousa
SZShen Zhao
Shen Zhao
NZNicolas F. Zorn
Nicolas F. Zorn
AYAbdurrahman Ali El Yumin
Abdurrahman Ali El Yumin
JZJana Zaumseil
Jana Zaumseil
The functionalization of single-walled carbon nanotubes (SWCNTs) with luminescent sp3 defects has greatly improved their performance in applications such as quantum light sources and bioimaging. Here, we report the covalent functionalization of purified semiconducting SWCNTs with stable organic radicals (perchlorotriphenylmethyl, PTM) carrying a net spin. This model system allows us to use the near-infrared photoluminescence arising from the defect-localized exciton as a highly sensitive probe for the short-range interaction between the PTM radical and the SWCNT. Our results point toward an increased triplet exciton population due to radical-enhanced intersystem crossing, which could provide access to the elusive triplet manifold in SWCNTs. Furthermore, this simple synthetic route to spin-labeled defects could enable magnetic resonance studies complementary to in vivo fluorescence imaging with functionalized SWCNTs and facilitate the scalable fabrication of spintronic devices with magnetically switchable charge transport.

20 November 2019 in Chemical Science
Verified
Journal Article
Open access
PDF file
ASAlejandro Sousa
Alejandro Sousa
FBFrancesc Bejarano
Francesc Bejarano
DGDiego Gutiérrez
Diego Gutiérrez
YLYann R. Leroux
Yann R. Leroux
ENEwa Malgorzata Nowik-Boltyk
Ewa Malgorzata Nowik-Boltyk
Núria CrivillersNúria Crivillers
Núria Crivillers
The incorporation of terminal alkynes into the chemical structure of persistent organic perchlorotriphenylmethyl (PTM) radicals provides new chemical tools to expand their potential applications. In this work, this is demonstrated by the chemical functionalization of two types of substrates, hydrogenated SiO2-free silicon (Si–H) and gold, and, by exploiting the click chemistry, scarcely used with organic radicals, to synthesise multifunctional systems. On one hand, the one-step functionalization of Si–H allows a light-triggered capacitance switch to be successfully achieved under electrochemical conditions. On the other hand, the click reaction between the alkyne-terminated PTM radical and a ferrocene azide derivative, used here as a model azide system, leads to a multistate electrochemical switch. The successful post-surface modification makes the self-assembled monolayers reported here an appealing platform to synthesise multifunctional systems grafted on surfaces.

13 August 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
TJTobias Junghoefer
Tobias Junghoefer
ENEwa Malgorzata Nowik-Boltyk
Ewa Malgorzata Nowik-Boltyk
ASAlejandro Sousa
Alejandro Sousa
EGErika Giangrisostomi
Erika Giangrisostomi
RORuslan Ovsyannikov
Ruslan Ovsyannikov
BCBenedetta Casu
Benedetta Casu
We have investigated the radical functionalization of gold with a derivative of the perchlorotriphenylmethyl radical using two methods: by chemisorption from the radical solution and by on surface chemical derivation from a precursor.

13 September 2020 in ACS Applied Electronic Materials
Verified
Journal Article
Closed access
DGDiego Gutiérrez
Diego Gutiérrez
ASAlejandro Sousa
Alejandro Sousa
Marta Mas-TorrentMarta Mas-Torrent
Marta Mas-Torrent
Núria CrivillersNúria Crivillers
Núria Crivillers